51 completed, 8 unknown, 5 active not recruiting, 5 terminated. 21 Not applicable, 16 Phase 1, 13 Phase 2, 9 Phase 3, 1 Phase 4.
Follow Influenza A: new trials by email Literature Review of Influenza A trials Research Report on Influenza A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Usability and Clinical Validation of the Flu A/B/COVID-19 + RSV Multiplex Rapid Test Flu A/B/COVID-19 + RSV Multiplex Rapid Test - SARS-CoV-2 Infection, Influenza A | Not applicable | Not yet recruiting | CorDx, Inc. | 1500 | 2026-11-01 | 2026-10-15 |
| Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp) Baloxavir, Placebo Control - Influenza A, Influenza B | Phase 3 | Recruiting | Unity Health Toronto | 264 | 2026-04-29 | 2026-08-18 |
| Clinical Validation of an At-Home Flu A/B and COVID-19 Rapid Test CorDx Tyfast Flu A/B & COVID-19 At-Home Multiplex Rapid Test - SARS-CoV-2 Infection, Influenza A | Not applicable | Not yet recruiting | CorDx, Inc. | 200 | 2026-02-12 | 2026-02-25 |
| Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A ZSP1273, Oseltamivir - Influenza a | Phase 3 | Active not recruiting | Guangdong Raynovent Biotech Co., Ltd | 119 | 2025-11-22 | 2025-12-16 |
| Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A ZSP1273, Placebo - Influenza A | Phase 3 | Active not recruiting | Guangdong Raynovent Biotech Co., Ltd | 157 | 2025-11-08 | 2025-12-16 |
| Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings Aptitude Medical Systems Respiratory Panel Test - COVID -19, Influenza A | Not applicable | Not yet recruiting | Aptitude Medical Systems | 2000 | 2025-11-01 | 2025-10-16 |
| Influenza A-associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit in China IPA and non-IPA groups - ICU, Invasive Pulmonary Aspergillosis | Completed | Jianfeng Xie | 542 | 2025-11-01 | 2026-01-09 | |
| A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA) AZD4117, AZD5315, Placebo - Influenza A | Phase 1 / Phase 2 | Active not recruiting | AstraZeneca | 405 | 2025-09-04 | 2026-10-09 |
| Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine QIV, QIV Control - Influenza, Human, Influenza, Human Prevention | Phase 3 | Not yet recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 4400 | 2025-02-08 | 2025-01-30 |
| Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use COVID/Flu Detect™ Rapid Self-Test - COVID-19, Influenza A | Completed | InBios International, Inc. | 899 | 2024-12-26 | 2025-05-22 | |
| Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A ZSP1273 granules - Influenza a | Phase 2 | Completed | Guangdong Raynovent Biotech Co., Ltd | 72 | 2024-11-30 | 2025-11-17 |
| Covid Flu A/B and RSV 4 in 1 Diagnostic Test Investigational Flu A/B Covid-19 and RSV Diagnostic Test - Influenza A, Influenza B | Completed | iHealth Labs inc | 1119 | 2024-11-15 | 2026-01-08 | |
| Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test Investigational Flu A/B And Covid-19 Diagnostic Test - COVID - 19, Influenza A | Completed | iHealth Labs inc | 588 | 2024-11-12 | 2026-01-08 | |
| Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine QIV, QIV control - Influenza, Human, Influenza a | Phase 1 | Active not recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 180 | 2024-10-13 | 2025-01-28 |
| A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients LIAISON NES FLU A/B, RSV & COVID-19 - Influenza a, Influenza B | Not applicable | Recruiting | DiaSorin Molecular LLC | 1000 | 2024-09-30 | 2024-11-04 |
| Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations Influenza Fluzone vaccine - Influenza A | Phase 4 | Completed | La Jolla Institute for Immunology | 23 | 2024-05-21 | 2026-02-12 |
| LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia LIAISON NES FLU A/B, RSV, & COVID-19, LIAISON PLEX Respiratory Flex Assay - Influenza A, Influenza Type B | Not applicable | Unknown | DiaSorin Molecular LLC | 1000 | 2024-05-06 | 2024-04-30 |
| Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI ILI Predictive Alerts, Reactive Content, and Proactive Content, ILI Predictive Alerts, Reactive Content, Proactive Content - Influenza, Influenza A | Not applicable | Completed | Evidation Health | 17043 | 2024-02-12 | 2024-09-19 |
| Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections Influenza, Human, COVID-19 | Completed | Evidation Health | 18157 | 2024-01-21 | 2024-09-05 | |
| A Prospective, Multicenter, Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza A Xuanfei Baidu Granule Placebo, Xuanfei Baidu Granule, Baloxavir Marboxil Tablet - Influenza A | Not applicable | Unknown | Capital Medical University | 584 | 2024-01-01 | 2024-01-16 |
Showing 20 of 75. Sign in to see all of them.
COVID-19 (27) · Influenza, Human (17) · Orthomyxoviridae Infections (5) · Respiratory Syncytial Virus Infections (5) · Adenoviridae Infections (2) · Coronavirus Infections (2) · Paramyxoviridae Infections (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Communicable Diseases, Emerging (1) · Coxsackievirus Infections (1) · Death (1) · Enterovirus Infections (1) · Infections (1) · Invasive Pulmonary Aspergillosis (1)
Infections (43) · RNA Virus Infections (43) · Respiratory Tract Diseases (41) · Virus Diseases (41) · Respiratory Tract Infections (38) · Coronaviridae Infections (28) · Nidovirales Infections (28) · Lung Diseases (27) · Pneumonia (27) · Pneumonia, Viral (27) · Coronavirus Infections (26) · Orthomyxoviridae Infections (15) · Mononegavirales Infections (6) · Pneumovirus Infections (5) · Paramyxoviridae Infections (4)
Oseltamivir (5) · ZSP1273 (4) · pimodivir (3) · Adjuvants, Pharmaceutic (2) · Reverse Transcriptase Polymerase Chain Reaction (2) · baloxavir (2) · Antiviral Agents (1) · Clarithromycin (1) · Cross-Sectional Studies (1) · Diagnostic Tests, Routine (1) · Diet (1) · Exercise (1) · Fatty Acids, Nonesterified (1) · Grippol (1) · Immunoglobulins, Intravenous (1)
Abbott Rapid Dx (5) · Guangdong Raynovent Biotech Co., Ltd (5) · Immune Targeting Systems Ltd (4) · DiaSorin Molecular LLC (3) · Evidation Health (3) · Janssen Research & Development, LLC (3) · LumiraDx UK Limited (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Aptitude Medical Systems (2) · Celltrion (2) · Cocrystal Pharma, Inc. (2) · CorDx, Inc. (2) · Ellume Pty Ltd (2) · Institute of Medical Biology, Chinese Academy of Medical Sciences (2) · The University of Hong Kong (2)
United States (38) · China (12) · Australia (11) · United Kingdom (8) · Canada (6) · Russia (6) · Belgium (5) · South Africa (5) · Spain (5) · Bulgaria (4) · Germany (4) · Latvia (4) · New Zealand (4) · South Korea (4) · Estonia (3)
Ernesto Ramirez, PhD (2) · Janet Farhang, PhD (2) · Teng Huang (2) · Andrew Pinto, MD (1) · Arnulfo Gonzalez-Cantu, MD (1) · Barry Lutz, PhD (1) · Bernardine McKellar (1) · Brad W Killingsworth, M.A. (1) · Brian DuChateau, PhD (1) · Buddy Creech, MD, MPH (1) · Candice Prowse (1) · Carlos Fierro, MD (1) · Christopher Chiu, BMBCh PhD (1)
PMID 39172627, PMID 25645025, PMID 28522352, PMID 28595644, PMID 30428049, PMID 31582358, PMID 33248473, PMID 36350017, PMID 36698795, PMID 36951890, PMID 37289541, PMID 38330975, PMID 38376227, PMID 39036981, PMID 40489986, PMID 42728468
2017 (2), 2014 (1), 2016 (1)